EXTRABROC® · Questions from ingredient buyers

Buyer FAQ

Answers to common questions about EXTRABROC® models, specifications, conversion, stability, testing, formats, documents and market status.

What is EXTRABROC® SFN made of?

EXTRABROC® SFN is an ingredient system designed around stable, sustained sulforaphane generation. It has three modules:

  • Standardized broccoli seed aqueous extract — the source of glucoraphanin, the precursor. The precursor comes from a water extract of broccoli seeds, not from chemical synthesis.
  • Active myrosinase — the enzyme that converts glucoraphanin to sulforaphane. Its activity determines conversion, and it is the part of the system most easily lost.
  • Food-grade stabilizing component — part of Fushan’s patented GRN-Myrosinase Co-Delivery System. It protects the precursor and the enzyme activity at ambient temperature.

The seed extract sets how much precursor goes in, myrosinase sets the conversion capacity, and the stabilizing component sets how much of both remains during ambient storage. EXTRABROC® GR-13 is the seed extract alone, specified by glucoraphanin content.

How is EXTRABROC® SFN different from a standard broccoli seed extract?

The difference is not the precursor content but how the ingredient is evaluated. A standard broccoli seed extract supplies glucoraphanin; whether it converts, how much converts and whether the result holds over the shelf life are outside its specification. EXTRABROC® SFN is evaluated by the sulforaphane it generates — ESY, Effective Sulforaphane Yield — rather than by the glucoraphanin stated on the label. Put simply: GR input versus SFN output. In practice, evaluation looks at the sulforaphane generated by the delivered ingredient under the acceptance-test method, and at its ability to keep generating sulforaphane over the shelf life.

Why not use sulforaphane itself?

Sulforaphane on its own is sensitive to heat, light and oxidation, so it needs special storage conditions and the content retained over time becomes the key question. EXTRABROC® SFN therefore supplies glucoraphanin, the stable precursor, together with myrosinase, so that sulforaphane is generated from the ingredient. See the questions on conversion and on testing below for how this is measured.

What is ESY, and why look beyond glucoraphanin content?

ESY (Effective Sulforaphane Yield) is Fushan’s evaluation approach. It considers three factors together: glucoraphanin content, glucoraphanin-to-sulforaphane conversion, and stability retention through storage and processing.

ESY (mg) = GRN intake (mg) ÷ 2.47 × conversion rate × stability-retention rate

The two rates are expressed as decimals. 2.47 is the molar mass ratio of glucoraphanin (free acid, about 437.5 g/mol) to sulforaphane (about 177.3 g/mol). Most products state glucoraphanin content, the input; ESY looks at the sulforaphane output. ESY describes a theoretical relationship between the three factors; it is not a dosing tool.

Under what conditions is the conversion rate measured, and how should it be read?

In-vitro conversion is a side-by-side comparison measured in simulated gastric fluid; it does not show conversion in the human body. Conversion in the body varies with individual gut microbiota, how and when a product is taken and the finished-product format, so it cannot be stated as a single number.

For the EXTRABROC® SFN Series, conversion is evaluated in simulated post-meal gastric fluid prepared according to the Chinese Pharmacopoeia, adjusted to pH 3.5, with pepsin, at 37 °C for 120 min. Under these conditions, from an initial 100 mg of glucoraphanin, the SFN Series generated 22.3 ± 1.2 mg of sulforaphane (n=3), a conversion rate of ≥55% (in vitro); the control without the enzyme generated <1 mg.

These are in-vitro results from Fushan’s own laboratory, used to compare formulations and control quality. They apply only to the test conditions above and do not represent conversion in humans. When comparing products, check that the test medium, pH and reaction time are the same.

How stable is EXTRABROC®, and how can stability be checked?

The TDS and label of each model state a two-year shelf life for unopened, intact packaging stored as specified.

Stability is evaluated by accelerated testing in a stability chamber: 40 °C ± 2 °C and 75% ± 5% RH, usually for 6 months, with samples taken at 0, 3 and 6 months and tested against the stability items. From the accelerated results, the shelf life of EXTRABROC® ingredients at 25 °C / 60% RH is extrapolated to ≥24 months.

Because this method takes months, we suggest also asking each supplier for its internal stability data for a side-by-side comparison.

Who manufactures EXTRABROC®?

EXTRABROC® is the own ingredient brand of Shenzhen Fushan Biotech Co., Ltd. Industrial production is contract manufacturing (OEM) by GANOHERB TECHNOLOGY (FUJIAN) CORPORATION, following Fushan’s process. Fushan provides and controls the seeds, process parameters and acceptance standards.

  • R&D and standards. Fushan defines the ratio of active myrosinase to glucoraphanin, the stabilization approach and the quality standards. Patent names and numbers are listed on the Quality & IP page.
  • Seeds. The seeds come from Fushan’s own broccoli lines FS08 and FS314, with seed glucoraphanin content ≥5.5% (company-reported).
  • Production and release. The contract manufacturer produces to Fushan’s process and Fushan accepts every batch, with limits on safety items such as moisture, microorganisms and heavy metals. Process validation on three consecutive batches showed a glucoraphanin content RSD below 3%.
  • Certificates and registrations. Fushan: U.S. FDA food facility registration No. 15731089098; D-U-N-S 561150415. GANOHERB TECHNOLOGY (FUJIAN) CORPORATION: GMP CN23/00006911, HACCP 001HACCP1700395, ISO 22000 001FSMS1700218, Kosher KC# 10804462-1 and Halal SSPY-201318-31930-R2-ADD (both list Broccoli Seed Extract).

Contract manufacturing is a common division of work in the functional ingredient industry. Every batch a buyer receives is governed by the same technical standards and acceptance rules, and batches are traceable and can be re-checked.

How large are the planting bases and the annual capacity?

The broccoli seed used for EXTRABROC® comes from high-glucoraphanin broccoli varieties bred by Fushan. The planting bases total about 200 hectares: about 133.3 ha in Yunnan and about 66.7 ha in Sichuan. Annual EXTRABROC® ingredient capacity is currently 50–80 tonnes, and both the planting area and the capacity are being expanded year by year. Share your volume and delivery window with us for supply planning.

How are EXTRABROC® ingredients tested on acceptance?

SFN Series (sulforaphane). Take 1 g of ingredient and add 200 g of water (do not use methanol or ethanol). Stir in a 37 °C water bath for 2 h, then measure sulforaphane by HPLC at 245 nm.

GR-13 (glucoraphanin). Take 0.5 g of ingredient and add 100 g of water. Sonicate for 10 min, then measure glucoraphanin by HPLC at 229 nm.

The SFN specification refers to the sulforaphane content measured after conversion under this method. This acceptance-test method is separate from the simulated gastric fluid test behind the ≥55% conversion figure. The batch COA is provided with your order or on request.

How do the ingredients flow and dissolve, which formats suit them, and what should production watch for?

EXTRABROC® ingredients flow well and dissolve well.

  • GR-13 can be used in powders, tablets, other solid formats and liquids.
  • The SFN Series is recommended for powders, tablets and other solid formats, with tablets and powders (solid drinks) preferred. It is not recommended for liquids.

Both lines absorb moisture: keep production and storage areas below 60% relative humidity and below 28 °C. For the SFN Series, keep process temperatures within 60 °C and avoid contact with water-containing liquids during production. In tablets, keep the ingredient within 50% of the formula; it can be added directly. In solid drinks it can be added directly as needed. Confirm suitability for your own formulation and process in your trials.

Is there clinical research behind EXTRABROC®?

ZHIYINGUOSU® is a tablet made with the EXTRABROC® SFN Series and produced by Shenzhen Fushan Biotech Co., Ltd. It has been used as the intervention product in human studies in several research areas. As of 20 October 2026, Fushan reports that eight of these studies are in public trial registries and four more are recorded under ethics approval or review numbers. The records are listed in the clinical studies section of the Science page.

Please note: these studies used the ZHIYINGUOSU® product, not the EXTRABROC® ingredient on its own. Because dosage form, excipients and process conditions differ, this evidence cannot be taken as evidence for a buyer’s own finished product.

How is EXTRABROC® related to ZHIYINGUOSU®?

ZHIYINGUOSU® tablets are made with the EXTRABROC® SFN Series and produced by Shenzhen Fushan Biotech Co., Ltd. The studies that used ZHIYINGUOSU® are listed with their registry or approval numbers in the clinical studies section. If you have a question about a specific record, the Fushan team can provide its full filing information.

Have a question that is not answered here?

Send it with your project details; our technical team will reply to you directly.

Ask our team

FDA statement

These statements have not been evaluated by the Food and Drug Administration. EXTRABROC® ingredients are supplied to manufacturers for further formulation and are not intended to diagnose, treat, cure, or prevent any disease.

Read the full regulatory notice

Cookie preferences

This website currently sets no analytics, advertising or tracking cookies. Your choice below is stored in your browser only and applies if optional categories are used in future.

Privacy policy